top of page
Vaccine Analysis Print

Vaccine Analysis Print (VAP) contains information on all UK spontaneous suspected Adverse Drug Reaction (ADR) reports collected by the Medicines and Healthcare Products Regulatory Agency from Yellow Card reports.

 

Please read Yellow Card Scheme â€‹guidelines to see who and how you can report suspected side effects.

 

VAPs have been acquired through 'What Do They Know' Freedom of Information (FOI) requests.

To view a downloadable pdf document, click on the year report was received. It might take a moment for the pdf document to be open on your browser. Scroll down to the second page to start reading the information presented.

DTaP/IPV/Hib/HepB 
Infanrix Hexa 
2022, 2024
Vaxelis 
2022, 2024

dTaP/IPV (booster) 
Boostrix-IPV 
2022, 2024

Td/IPV 
Revaxis 
2022, 2024
MenB
Bexero 

2022, 2024

Hib/MenC
Menitorix 

2022, 2024 

Rotavirus
Rotarix 

2022, 2024
Pneumococcal conjugate vaccine (PCV)
Prevenar 13

2022, 2024

MMR
MMRvaxPro

2022, 2024
Priorix 
2022, 2024

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Patients and healthcare professionals are asked to report any suspected adverse reactions via the national reporting system Yellow Card Scheme.

bottom of page